COST Action BM0607 on Targeted Radionuclide Therapy created a short film on the application of radiolabeled peptides for targeted therapy; 177Lu-DOTA-octreotate emits gamma and beta particle radiation, the peptide molecules bind somatostatin receptors on tumor cells and can be applied for both tumor imaging and radionuclide therapy.
12/07/2018